AUS
NZ
UK
CA
USA
IND
Some stocks are making headlines in the past couple of days, setting them apart from the crowd. Some major fundamental changes have been noticed in these stocks that helped them to surge to as high as 30% in a single day. Hereâs a brief look at these skyrocketing stocks:
- Copper Mountain Mining Corporation (ASX:C6C)
On 26th February 2019, mining player, Copper Mountain Mining Corporation had updated about its current operations. The company announced its mine production plan for its copper mountain properties, southern British Columbia. The results include a 102% increase in mineral reserves, a 21% increase in the average annual copper production to 93 million pounds over the first ten years and cutting down on their C1 cash cost to US$ 1.87 per pound produced.
The approximate average cash cost, net of by-product credits is approximately US$1.74 per pound of copper for the first ten years starting in 2020 and US$1.87 per pound of copper over the life of mine. The overall increase in the Copper and Gold production, extended mine life with lower cash cost took the stock price 30% up as on 26th February to 2019 to A$1.1 from the previous closing of A$0.85. Today, 27 February, the stock however corrected 3.17% down, settling at A$1.070.
- Experience Co Limited (ASX:EXP)
Experience Co surprised the investors after posting their strong 1HFY19 numbers on 26th February 2019. The revenue jumped by more than 42% to $84.3 million in 1HFY19 from $59.2 million in 1HFY18. EBITDA also rose from $11.2 million in 1HFY18 to $17.6 million in 1HFY19, an increase of 57.1%. This led to a consequent increase in the net profit after tax (NPAT) from $6 million in 1HFY18 to $7.2 million in 1HFY19. On every major front, the company delivered on the investors' expectation which was evident in the stock price as well. On 26th February 2019, the stock rose by more than 17.3% on ASX and settled the day at A$0.305 from the previous closing of A$0.26. Even today, 27 February, the stock soared by 11.475% to A$3.40 at the end of trading session.
- Enevis Limited (ASX:ENE)
Enevis Limited declared its impressive 1HFY19 results on 21st February 2019. The sales for the 1HFY19 improved by 56% to $19.91 million from the 1HFY18 sales of $12.77 million. Net profit was the main turnaround for the business compared to the previous corresponding year. Net profit for 1HFY19 stood at $94,679 compared to a net loss of $2.28 million in 1HFY18. The balance sheet also showed a good picture. The total assets grew from $9.23 million (as at 30th June 2018) to $15.19 million (as at 31st December 2018) while the total liabilities grew moderately from $12.27 million to $13.36 million in the same period. All these numbers were taken positively and contributed to the 23.8% rise in the share price and settling at A$0.26 as on 26th February 2019. The stock traded flat at same price on 27th February with no daily volume. The stock has a very low volume; therefore, one needs to be cautious.
- Neurotech International Limited (ASX:NTI)
On 25th February 2019, Neurotech International gave an update regarding the rights issue of shares on pro-rata basis which had already been closed on 20 February 2019. The company received applications for 26,122,966 shares to raise $783,689 (before costs). This represents 23,521,466 shares applied for under the Rights Issue. The stock significantly opened gap up on 25th February 2019 but lost all the gains within the same day. The average trading volume of the stock is quite less, but this development may lead to a good action in the coming days. The stock was up by 7.69% and traded at A$0.028 from the previous closing of A$0.026 on 26 February. Today, 27 February, the stock traded flat with daily volume of 104,328.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
